Research Use Only.
CorpX software is for Research Use Only. It is not approved or cleared by any regulatory authority for clinical diagnosis, treatment selection, or patient management, and must not be used as the basis of a clinical decision.
Intended use
CorpX is a quantitative analytics platform for medical imaging. It is intended for:
- Research — quantifying imaging cohorts for scientific investigation
- Clinical trials and pharmaceutical research — reproducible imaging measurements as study or exploratory endpoints
- Pre-clinical research — quantification of pre-clinical imaging
- Method development and validation — building and testing quantitative imaging methods
Not intended for
- Diagnosing disease or determining its absence
- Selecting, guiding, or monitoring treatment for an individual patient
- Any use where a clinical decision depends on the output
- Use as a stand-alone medical device or as part of one, unless separately cleared
Why we say this so directly
Quantitative imaging becomes clinically useful only when it has been validated for a defined clinical purpose and cleared under the applicable regulatory framework. We have not made that claim, so we don’t imply it. Everything CorpX produces is a measurement, not an interpretation — and every measurement is traceable to the method and the scan it came from.
Our regulatory approach
We enter through research and trial analytics, where quantitative imaging is valuable today and does not require device clearance. Clinical use is a later, deliberate step: it requires validation on defined populations, evidence that survives peer review, and the appropriate regulatory pathway.
Data and patient safety
This website does not receive medical images or patient data. Imaging analyzed under research collaboration is handled under a separate written agreement, with de-identification and safeguards appropriate to health data. See our Privacy notice and Security page.
Questions
Regulatory and compliance enquiries: anamaria.chioran@corpxanalytics.com